Robert Düster

6PUBLICATIONS
24CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 20, 2024
RNA-binding proteins hnRNPM and ELAVL1 promote type-I interferon induction downstream of the nucleic acid sensors cGAS and RIG-I.

Alexander Kirchhoff, Anna-Maria Herzner, Christian Urban

|Aug 03, 2024
Structural basis of Cdk7 activation by dual T-loop phosphorylation.

Robert Düster, Kanchan Anand, Sophie C Binder

|Feb 26, 2024
Structural basis of Cdk7 activation by dual T-loop phosphorylation.

Robert Düster, Kanchan Anand, Sophie C Binder

|Apr 12, 2022
Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors.

Kai Funke, Robert Düster, Prince De-Graft Wilson

|Mar 16, 2022
Functional characterization of the human Cdk10/Cyclin Q complex.

Robert Düster, Yanlong Ji, Kuan-Ting Pan

|Nov 17, 2021
Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.

Ines H Kaltheuner, Kanchan Anand, Jonas Moecking

Pageof 1